Sign in Register

Drug class

Systemic Xerostomia Agents

Although not designated as a formal, standalone classification term by the U.S. Read more about Systemic Xerostomia Agents

23 drugs in this class 19 manufacturers

Related classes & indications

Iron Chelating AgentsOther therapeutic classes · 45 prescription drugs Phosphodiesterase-4 (PDE4) inhibitorsOther therapeutic classes · 20 prescription drugs Xerostomia Secondary To Sjogren's SyndromeTop indication · 36 prescription drugs

Showing 10–18 of 23 drugs

Sort

PILOCARPINE HCL

SYSTEMIC XEROSTOMIA AGENTS · XEROSTOMIA ·+2

AVPAK

SALAGEN (pilocarpine HCl)

SYSTEMIC XEROSTOMIA AGENTS · XEROSTOMIA ·+2

CONCORDIA PHARM

PILOCARPINE HCL

SYSTEMIC XEROSTOMIA AGENTS · XEROSTOMIA ·+2

BRYANT RANCH PR

CEVIMELINE HCL

SYSTEMIC XEROSTOMIA AGENTS · XEROSTOMIA SECONDARY TO SJOGREN'S SYNDROME

AUROBINDO PHARM

PILOCARPINE HCL

SYSTEMIC XEROSTOMIA AGENTS · XEROSTOMIA ·+2

AUROBINDO PHARM

CEVIMELINE HCL

SYSTEMIC XEROSTOMIA AGENTS · XEROSTOMIA SECONDARY TO SJOGREN'S SYNDROME

BIONPHARMA INC.

CEVIMELINE HCL

SYSTEMIC XEROSTOMIA AGENTS · XEROSTOMIA SECONDARY TO SJOGREN'S SYNDROME

ADVAGEN PHARMA

CEVIMELINE HCL

SYSTEMIC XEROSTOMIA AGENTS · XEROSTOMIA SECONDARY TO SJOGREN'S SYNDROME

Cosette Pharmaceuticals

CEVIMELINE HCL

SYSTEMIC XEROSTOMIA AGENTS · XEROSTOMIA SECONDARY TO SJOGREN'S SYNDROME

PD-RX PHARM

Filter & compare in the drug finder → Opens the drug finder with Systemic Xerostomia Agents preselected. Add indication or manufacturer filters there.

About Systemic Xerostomia Agents.

Although not designated as a formal, standalone classification term by the U.S.

Food and Drug Administration, systemic xerostomia agents—more formally classified as systemic sialogogues or oral cholinergic agonists—refer to systemically administered medications used to treat severe dry mouth.

These agents, primarily pilocarpine and cevimeline, act by stimulating muscarinic acetylcholine receptors within functional exocrine tissues to induce endogenous saliva production.

They are clinically indicated to alleviate oral dryness in autoimmune disorders, most notably Sjögren disease, and to manage radiation-induced salivary gland hypofunction following head and neck cancer therapy.

nih.gov
Although not designated as a formal, standalone classification term by the U.S. Food and Drug Administration, systemic xerostomia agents—more formally classified as systemic sialogogues or oral cholinergic agonists—refer to systemically administered medications used to treat severe dry mouth These agents, primarily pilocarpine and cevimeline, act by stimulating muscarinic acetylcholine receptors within functional exocrine tissues to induce endogenous saliva production They are clinically indicat...
ada.org
Although not designated as a formal, standalone classification term by the U.S. Food and Drug Administration, systemic xerostomia agents—more formally classified as systemic sialogogues or oral cholinergic agonists—refer to systemically administered medications used to treat severe dry mouth They are clinically indicated to alleviate oral dryness in autoimmune disorders, most notably Sjögren disease, and to manage radiation-induced salivary gland hypofunction following head and neck cancer thera...
mdpi.com
Although not designated as a formal, standalone classification term by the U.S. Food and Drug Administration, systemic xerostomia agents—more formally classified as systemic sialogogues or oral cholinergic agonists—refer to systemically administered medications used to treat severe dry mouth
cdeworld.com
These agents, primarily pilocarpine and cevimeline, act by stimulating muscarinic acetylcholine receptors within functional exocrine tissues to induce endogenous saliva production
mayoclinic.org
They are clinically indicated to alleviate oral dryness in autoimmune disorders, most notably Sjögren disease, and to manage radiation-induced salivary gland hypofunction following head and neck cancer therapy